Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 266,700 | 242,500 | 184,400 | 221,000 | 184,600 |
| Cost of Goods | 98,100 | 88,900 | 65,500 | 67,500 | 57,600 |
| Gross Profit | 168,600 | 153,600 | 118,900 | 153,500 | 127,000 |
| Operating Expenses | 154,800 | 159,400 | 150,100 | 142,000 | 128,100 |
| Operating Income | 13,900 | -4,900 | -30,700 | 12,000 | -500 |
| Interest Expense | 4,900 | 4,800 | 4,800 | 4,700 | 4,500 |
| Other Income | 35,800 | 39,300 | 11,500 | 1,300 | 2,500 |
| Pre-tax Income | 44,800 | 29,600 | -24,000 | 8,600 | -2,500 |
| Income Tax | -1,800 | -600 | 200 | 18,000 | -500 |
| Net Income Continuous | 46,600 | 30,200 | -24,200 | -9,400 | -2,000 |
| Net Income | $46,600 | $30,200 | $-24,200 | $-9,400 | $-2,000 |
| EPS Basic Total Ops | 0.13 | 0.09 | -0.07 | -0.03 | -0.01 |
| EPS Basic Continuous Ops | 0.13 | 0.09 | -0.07 | -0.03 | -0.01 |
| EPS Diluted Total Ops | 0.13 | 0.09 | -0.07 | -0.03 | -0.01 |
| EPS Diluted Continuous Ops | 0.13 | 0.08 | -0.07 | -0.03 | -0.01 |
| EBITDA(a) | $21,700 | $1,800 | $-24,700 | $16,200 | $3,800 |